Pay in 4 interest-free payments of $6.82 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Key published studies include: Teichman et al., 2006 (JCEM): Dose-dependent GH and IGF-1 elevation with CJC-1295 DAC in healthy adults Raun et al., 1998 (Eur J Endocrinol): Ipamorelin demonstrated selective GH release without cortisol/prolactin elevation Johansen et al., 1999: Phase I/II Ipamorelin trial showed dose-response relationship with no significant adverse effects Bowers et al., 2004: Foundational research on GHRH/GHRP synergistic GH release mechanisms Neither CJC-1295 nor Ipamorelin has completed Phase 3 clinical trials
"CMS Announces BALANCE Model for GLP-1 Access." Medicare GLP-1 Payment Demonstration begins July 2026 ($50/month out-of-pocket)
Weight loss without exercise is possible on semaglutide, but the composition of that weight loss changes dramatically
When injecting Wegovy into the stomach, the area below your ribs and above the hip, at least 2 inches away from the belly button is the best choice because the belly button is a connective tissue called fascia that cannot absorb medication
87% have seen life-changing results* 93% agree Ro is easier to incorporate into their lives* 97% report silenced or quieter food noise since starting* Average weight loss in 1 year is 11-20% (vs ~2-3% with diet and exercise alone)
